Cheng Dan Fong

Title: Cheng Dan Fong: Innovator in Enamel Matrix Related Polypeptides

Introduction

Cheng Dan Fong is a notable inventor based in Huddinge, Sweden. He has made significant contributions to the field of biotechnology, particularly in the development of nucleic acids related to enamel matrix polypeptides. With a total of 2 patents, his work has the potential to impact the treatment of hard tissue diseases.

Latest Patents

Cheng Dan Fong's latest patents include innovative inventions that focus on nucleic acids encoding enamel matrix related polypeptides. The first patent describes novel nucleic acid fragments that mediate contact between enamel and cell surfaces. This invention also encompasses expression vectors for protein production, methods for producing the polypeptide, and compositions that include these polypeptides. The second patent mirrors the first, emphasizing the same nucleic acid fragments and their applications in treating various hard tissue diseases or disorders.

Career Highlights

Cheng Dan Fong is currently associated with Biora AB, where he continues to advance his research and development efforts. His work is pivotal in the field of dental and hard tissue regeneration, showcasing his commitment to innovation and scientific progress.

Collaborations

Cheng has collaborated with notable colleagues such as Radim Cerny and Ivan Slaby, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Cheng Dan Fong's contributions to the field of biotechnology, particularly through his patents on enamel matrix related polypeptides, highlight his role as a significant inventor. His work not only advances scientific knowledge but also holds promise for future medical applications.